Intravenous antazoline, a first-generation antihistaminic drug with antiarrhythmic properties, is a suitable agent for pharmacological cardioversion of atrial fibrillation induced during pulmonary vein isolation due to the lack of influence on atrio-venous conduction and high clinical effectiveness (AntaEP Study).
Michal Miroslaw FarkowskiAleksander MaciagIlona KowalikMarek KonkaHanna SzwedMariusz PytkowskiPublished in: British journal of clinical pharmacology (2019)
Due to the lack of influence on atrio-venous conduction and high clinical effectiveness, antazoline may be suitable for pharmacological cardioversion of AF occurring during AF ablation.